Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy
Top Cited Papers
- 1 November 2002
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (21), 4368-4380
- https://doi.org/10.1200/jco.2002.10.088
Abstract
Vascular endothelial growth factor A (VEGF-A), the founding member of the vascular permeability factor (VPF)/VEGF family of proteins, is an important angiogenic cytokine with critical rol...Keywords
This publication has 150 references indexed in Scilit:
- VEGF–VEGF receptor complexes as markers of tumor vascular endotheliumJournal of Controlled Release, 2001
- Vascular targeting of solid and ascites tumours with antibodies to vascular endothelial growth factorEuropean Journal Of Cancer, 1996
- Identification of a Natural Soluble Form of the Vascular Endothelial Growth Factor Receptor, FLT-1, and Its Heterodimerization with KDRBiochemical and Biophysical Research Communications, 1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endotheliumNature, 1995
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.Proceedings of the National Academy of Sciences, 1993
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971